Skip to main content

Advertisement

Log in

Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

Silent myocardial ischaemia—as evaluated by stress-induced perfusion defects on myocardial perfusion scintigraphy (MPS) in patients without a history of chest pain—is frequent in diabetes and is associated with increased rates of cardiovascular events. Its prevalence has been determined in asymptomatic diabetic patients, but remains largely unknown in diabetic patients with suspected coronary artery disease (CAD) in the clinical setting. In this study we therefore sought (a) to determine the prevalence of symptomatic and silent perfusion defects in diabetic patients with suspected CAD and (b) to characterise the eventual predictors of abnormal perfusion.

Methods

The patient population comprised 133 consecutive diabetic patients with suspected CAD who had been referred for MPS. Studies were performed with exercise (41%) or pharmacological stress testing (1-day protocol, 99mTc-sestamibi, 201Tl or both). We used semi-quantitative analysis (20-segment polar maps) to derive the summed stress score (SSS) and the summed difference score (SDS).

Results

Abnormal MPS (SSS≥4) was observed in 49 (37%) patients (SSS=4.9±8.4, SDS=2.4±4.7), reversible perfusion defects (SDS≥2) in 40 (30%) patients [SSS=13.3±10.9; SDS=8.0±5.6; 20% moderate to severe (SDS>4), 7% multivessel] and fixed defects in 21 (16%) patients. Results were comparable between patients with and patients without a history of chest pain. Of 75 patients without a history of chest pain, 23 (31%, 95% CI=21–42%) presented reversible defects (SSS=13.9±11.3; SDS=7.4±1.2), indicative of silent ischaemia. Reversible defects were associated with inducible ST segment depression during MPS stress [odds ratio (OR)=3.2, p<0.01). Fixed defects were associated with erectile dysfunction in males (OR=3.7, p=0.02) and lower aspirin use (OR=0.25, p=0.02).

Conclusion

Silent stress-induced perfusion defects occurred in 31% of the patients, a rate similar to that in patients with a history of chest pain. MPS could identify these patients with a potentially increased risk of cardiovascular events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414–31.

    CAS  PubMed  Google Scholar 

  2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434–44.

    CAS  PubMed  Google Scholar 

  3. Klein J, Chao SY, Berman DS, Rozanski A. Is ‘silent’ myocardial ischemia really as severe as symptomatic ischemia? The analytical effect of patient selection biases. Circulation 1994;89:1958–66.

    CAS  PubMed  Google Scholar 

  4. Fowler PB. The UK prospective diabetes study. Lancet 1998;352:1933; author reply 1934.

    CAS  Google Scholar 

  5. Passa P, Drouin P, Issa-Sayegh M, Blasco A, Masquet C, Monassier JP, Paillole C. Coronary disease and diabetes. Diabetes Metab 1995;21:446–51.

    CAS  Google Scholar 

  6. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998;21:1551–9.

    PubMed  Google Scholar 

  7. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. A consensus conference organised by the British Cardiac Society, the British Nuclear Cardiology Society and the British Nuclear Medicine Society, endorsed by the Royal College of Physicians of London and the Royal College of Radiologists. Eur J Nucl Med Mol Imaging 2004;31:261–91. DOI 10.1007/s00259-003-1344-5.

    Article  CAS  PubMed  Google Scholar 

  8. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025–32.

    CAS  PubMed  Google Scholar 

  9. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32–40.

    Article  Google Scholar 

  10. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. Br Med J 1990;301:92–5.

    CAS  Google Scholar 

  11. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 1997;79:134–9. DOI 10.1016/S0002-9149(96)00699-6.

    Article  Google Scholar 

  12. Weiner DA, Ryan TJ, Parsons L, Fisher LD, Chaitman BR, Sheffield LT, Tristani FE. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol 1991;68:729–34.

    Article  Google Scholar 

  13. Wackers FJT, Young LH, Inzucchi SE, Chyun DA, Davey JA. Detection of ischemia in asymptomatic diabetics: preliminary results of the DIAD study. J Am Coll Cardiol 2003;41:409a.

    Article  Google Scholar 

  14. Rose G, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd edn. Geneva: WHO; 1982.

  15. Imaging guidelines for nuclear cardiology procedures, part 2. American Society of Nuclear Cardiology. J Nucl Cardiol 1999;6:G47–84.

    Article  Google Scholar 

  16. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455–64.

    CAS  PubMed  Google Scholar 

  17. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535–43.

    CAS  PubMed  Google Scholar 

  18. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999;22:1396–400.

    CAS  PubMed  Google Scholar 

  19. Vanzetto G, Halimi S, Hammoud T, Fagret D, Benhamou PY, Cordonnier D, et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999;22:19–26.

    CAS  PubMed  Google Scholar 

  20. Inoguchi T, Yamashita T, Umeda F, Mihara H, Nakagaki O, Takada K, et al. High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 2000;47:37–44. DOI 10.1016/S0168-8227(99)00102-3.

    Article  Google Scholar 

  21. De Lorenzo A, Lima RSL, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002;90:827–32. DOI 10.1016/S0002-9149(02)02702-9.

    Article  Google Scholar 

  22. Wackers F, Young L, Inzucchi S, Chyun D, Davey J. The prevalence of silent myocardial ischemia in asymptomatic patients with type 2 diabetes meltitus: results of the DIAD study. Diabetes 2003;52:A56.

    Google Scholar 

  23. Wackers FTJ, Young LH, Chyun DA, Davey JA, Inzucchi SE. Predictors of silent myocardial ischemia in patients with type 2 diabetes mellitus: results from the DIAD study. Diabetologia 2003;46:A23–4.

    Google Scholar 

  24. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980;18:279–83.

    CAS  PubMed  Google Scholar 

  25. Zaret B, Beller GA. Nuclear cardiology—state of the art and future directions. 2nd edn. St. Louis: Mosby; 1999.

  26. Pancholy SB, Schalet B, Kuhlmeier V, Cave V, Heo J, Iskandrian AS. Prognostic significance of silent ischemia. J Nucl Cardiol 1994;1:434–40.

    CAS  PubMed  Google Scholar 

  27. Valensi P, Sachs RN, Lormeau B, Taupin JM, Ouzan J, Blasco A, et al. Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. Diabetes Metab 1997;23:409–16.

    CAS  PubMed  Google Scholar 

  28. Cosson E, Guimfack M, Paries J, Paycha F, Attali JR, Valensi P. Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events? Diabetes Metab 2003;29:470–6.

    CAS  PubMed  Google Scholar 

  29. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345–52.

    CAS  PubMed  Google Scholar 

  30. Schindler TH, Nitzsche E, Magosaki N, Brink I, Mix M, Olschewski M, et al. Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation. Heart 2003;89:517–26.

    Article  Google Scholar 

  31. Hasdai D, Gibbons RJ, Holmes Jr DR, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997;96:3390–5.

    CAS  PubMed  Google Scholar 

  32. Blumenthal RS, Becker DM, Yanek LR, Aversano TR, Moy TF, Kral BG, Becker LC. Detecting occult coronary disease in a high-risk asymptomatic population. Circulation 2003;107:702–7. DOI 10.1161/01.CIR.0000048127.93169.88.

    Article  Google Scholar 

  33. Verna E, Ceriani L, Giovanella L, Binaghi G, Garancini S. “False-positive” myocardial perfusion scintigraphy findings in patients with angiographically normal coronary arteries: insights from intravascular sonography studies. J Nucl Med 2000;41:1935–40.

    CAS  PubMed  Google Scholar 

  34. Nitenberg A, Ledoux S, Valensi P, Sachs R, Attali JR, Antony I. Impairment of coronary microvascular dilation in response to cold pressor-induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes 2001;50:1180–5.

    CAS  PubMed  Google Scholar 

  35. Nitenberg A, Valensi P, Sachs R, Cosson E, Attali JR, Antony I. Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors. Diabetes Care 2004;27:208–15.

    PubMed  Google Scholar 

  36. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899–906.

    CAS  PubMed  Google Scholar 

  37. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653–8. DOI 10.1161/01.CIR.0000025404.78001.D8.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the help of our nuclear medicine technician staff and of our physicians in performing the clinical studies (Drs. A. Boubaker, M.-F. Bézy, N. Besseghir, V. Vaclavik, M. Piller, G. Storto, G. Barghouth, J.-P. Willi, C. Müller, C. Antonescu, F. Bonvin and M. Zwimpfer). We are also greatly indebted to Prof. H.R. Schelbert, Drs. T.H. Schindler and X.-L. Zhang (Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, USA) for critical comments and suggestions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John O. Prior.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prior, J.O., Monbaron, D., Koehli, M. et al. Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy. Eur J Nucl Med Mol Imaging 32, 60–69 (2005). https://doi.org/10.1007/s00259-004-1591-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-004-1591-0

Keywords

Navigation